malignant, growth, gland, men, bladder, bones, grow, older

EDAP TMS introduces Albatherm HIFU device for prostate cancer in Chinese healthcare market
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it will expand into the rapidly growing Chinese healthcare market with its Albatherm HIFU device for the treatment of prostate cancer. Ablatherm HIFU will be distributed throughout China by Shaw Han Biomedical Co. Ltd.

Scientific findings provide new information on prostate cancer care
A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study finds that treatments that may be less expensive

Research finds increased diagnostic activity among men with family history of prostate cancer
The brothers of men with prostate cancer are at an increased risk of prostate cancer diagnosis because of increased diagnostic activity and not necessarily because they carry a genetic mutation that increases risk of the disease, according to a study published online August 19 in The Journal of

Us TOO International Prostate Cancer Education & Support Network recognized for 20 years of service
The prostate cancer community joins together in congratulating Us TOO International Prostate Cancer Education & Support Network in their 20th anniversary of continued prostate cancer support, education and advocacy.

Loyola University Medical Center to offer free prostate cancer screenings
More than 55 million American men are at risk for developing prostate cancer, according to the American Cancer Society. This year more than 27,000 men are expected to die of the disease, which is the second-leading cause of cancer death in men.

Robotic prostatectomy has low complication rates: CINJ study
According to a new study by The Cancer Institute of New Jersey (CINJ), new evidence proves the safety of a robotic prostatectomy with the lowest complication rates in prostate cancer treatment. This comes as no surprise to Dr. David Samadi, Chief of the Division of Robotics and Minimally

Daily dose of aspirin may reduce prostate cancer risk: US Study
A US study has found that a daily dose of aspirin may reduce the risk of prostate cancer, but Cancer Research UK has noted that regular use of aspirin can cause serious side-effects and should not be undertaken unless recommended by a doctor.Several previous studies have looked at

Problems with analytical study design and data misinterpretation leads to biomarker failure: Report
The boom in cancer biomarker investments over the past 25 years has not translated into major clinical success. The reasons for biomarker failures include problems with study design and interpretation, as well as statistical deficiencies, according to an article published online August 12 in The Journal of the

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of

Progenics announces EMA CHMP positive opinion for RELISTOR in pre-filled syringes
Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has issued a positive opinion for RELISTOR® (methylnaltrexone bromide) subcutaneous injection in pre-filled syringes.

Latest Searches: white, fasr typepad com p12 html, human, youtoupxxx, fasr typepad com p13 html, cancer, sleep, kbadmintonclub, severe, birth, WJGpTVAOKeQyY, hydr ull sho, pharmacy, modular math washington e, medullary, federal. Top Searches...

Common typos for 'Prostate-Cancer' : prostate ccancer, potate cancer, prostate c ancer, prostate cwncer, rostatte cancer, prostate ccan cer, prostate cacner, prostate canc er, rpostate cancer, prostatecancer, pros tate c-ancer, proostate cancer, prostate cnacer, prostate cancerr, prostateacncer, prosta te canxer, proostat ecancer, protsate cancer, pro-stat4 cancer, prostate ca n cer, prosttae cancer, prostate cance4, prosta te cancer, pr-ostate cancer, prostate ancer, orostate ccancer, prost ate cancer, prostaa te cancer.
More 'Prostate-Cancer' Typos...